Logo

Bruker BioScience Shareholders Approve Acquisition of Bruker Optics

Jun 29, 2006
NEW YORK (GenomeWeb News) - Bruker BioSciences shareholders overwhelmingly voted to approve the acquisition of molecular spectroscopy company Bruker Optics at today's annual meeting, the company said.
 
The $135 million deal, announced in April, would be paid approximately 59 percent in cash and 41 percent in the company's stock.
 
The board of directors of Bruker Optics and the independent directors on the board of directors for Bruker BioSciences previously approved the acquisition unanimously.
 
The transaction is expected to close in early July.

Breaking News
The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.